Suzanne Luck

3.8k citations
45 papers · 5.3k · 7 hit papers · h-index 24

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
    • Cytomegalovirus and herpesvirus research
    • Sepsis Diagnosis and Treatment

Papers in

Suzanne Luck

45 papers receiving 5.1k citations

Suzanne Luck's Hit Papers

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial 2023 · 84 citations
840+3+7Years since publication5001k1.5k

Peers

Suzanne Luck
Comparison fields: 5 of 106
  • Infectious Diseases 2.4k
  • Epidemiology 1.7k
  • Applied Microbiology and Biotechnology 73
  • Sensory Systems 58
  • Internal Medicine 31
Replace Paula Hutton with:
Paula Hutton United Kingdom
Kathryn A. Puxty United Kingdom
David Benjamin Antcliffe United Kingdom
Robin Brittain-Long United Kingdom
Srini Bandi United Kingdom
David B. Lieberman Israel
Nicola Coppola Italy
Stuart Hartshorn United Kingdom
Louis Grandjean United Kingdom
Stephen Kegg United Kingdom
Suzanne Luck relative to Paula Hutton United Kingdom Paula Hutton's profile →
Citations per field
00.5×2×4×6×8×9.7×
Paula Hutton · 1×
Citations per year

Countries citing papers authored by Suzanne Luck

Since Specialization
Citations

This map shows the geographic impact of Suzanne Luck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Luck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Luck more than expected).

Fields of papers citing papers by Suzanne Luck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Luck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Luck. The network helps show where Suzanne Luck may publish in the future.

Co-authors

The 25 scholars most cited alongside Suzanne Luck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne Luck Line = papers co-authored together Suzanne Luck links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
20211531
2
Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease
Hit paper breakdown →
2015614
3
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021411
4
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021393
5 2011339
6
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
7 2017234
8
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022231
9 2021213
10 200399
11
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
202384
12 202077
13 201175
14 201468
15 202067
16 200857
17 201551
18 200948
19 201839
20 201636

About Suzanne Luck

Suzanne Luck is a scholar working on Epidemiology, Infectious Diseases, Physiology, Public Health, Environmental and Occupational Health and Applied Microbiology and Biotechnology, having authored 45 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (26 papers), COVID-19 Clinical Research Studies (10 papers), Neonatal and Maternal Infections (3 papers), Syphilis Diagnosis and Treatment (3 papers), Kawasaki Disease and Coronary Complications (1 paper), Bacterial Infections and Vaccines (1 paper), Sepsis Diagnosis and Treatment (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Infectious Diseases (2.4k citations), Epidemiology (1.7k citations), Applied Microbiology and Biotechnology (73 citations), Sensory Systems (58 citations) and Internal Medicine (31 citations). Suzanne Luck has collaborated with scholars based in United Kingdom, Spain and Australia. Frequent co-authors include Mike Sharland, P. D. Griffiths, Rana Chakraborty, Seilesh Kadambari, Eleri Williams, Claire E. Atkinson, Paul Trafford Heath, Daniel Blázquez‐Gamero, Simone Walter and Janet Elizabeth Berrington. Their work appears in journals such as The Lancet, Archives of Disease in Childhood Fetal & Neonatal, Archives of Disease in Childhood, The Pediatric Infectious Disease Journal and Journal of Clinical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact